Abbott Laboratories (ABT)
99.34
+0.85
(+0.86%)
USD |
NYSE |
Oct 09, 12:55
Abbott Laboratories Enterprise Value : 198.08B for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 198.08B |
| October 07, 2026 | 198.50B |
| October 06, 2026 | 197.51B |
| October 05, 2026 | 200.87B |
| October 02, 2026 | 196.37B |
| October 01, 2026 | 194.97B |
| September 30, 2026 | 198.67B |
| September 29, 2026 | 202.34B |
| September 28, 2026 | 202.39B |
| September 25, 2026 | 202.93B |
| September 24, 2026 | 202.55B |
| September 23, 2026 | 206.73B |
| September 22, 2026 | 207.08B |
| September 21, 2026 | 205.85B |
| September 18, 2026 | 205.21B |
| September 17, 2026 | 204.55B |
| September 16, 2026 | 204.78B |
| September 15, 2026 | 204.21B |
| September 14, 2026 | 206.04B |
| September 11, 2026 | 204.07B |
| September 10, 2026 | 206.51B |
| September 09, 2026 | 209.75B |
| September 08, 2026 | 210.25B |
| September 04, 2026 | 215.11B |
| September 03, 2026 | 215.91B |
| Date | Value |
|---|---|
| September 02, 2026 | 218.81B |
| September 01, 2026 | 216.15B |
| August 31, 2026 | 218.62B |
| August 28, 2026 | 222.27B |
| August 27, 2026 | 220.75B |
| August 26, 2026 | 225.09B |
| August 25, 2026 | 228.61B |
| August 24, 2026 | 229.54B |
| August 21, 2026 | 229.49B |
| August 20, 2026 | 225.16B |
| August 19, 2026 | 225.66B |
| August 18, 2026 | 222.64B |
| August 17, 2026 | 218.64B |
| August 14, 2026 | 220.16B |
| August 13, 2026 | 220.20B |
| August 12, 2026 | 219.57B |
| August 11, 2026 | 217.51B |
| August 10, 2026 | 215.61B |
| August 07, 2026 | 214.21B |
| August 06, 2026 | 214.47B |
| August 05, 2026 | 210.58B |
| August 04, 2026 | 210.14B |
| August 03, 2026 | 213.02B |
| July 31, 2026 | 210.56B |
| July 30, 2026 | 210.40B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Becton, Dickinson & Co. | 65.72B |
| Boston Scientific Corp. | 73.04B |
| DexCom, Inc. | 31.31B |
| Globus Medical, Inc. | 9.361B |
| Intuitive Surgical, Inc. | 141.90B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 928.00M |
| Revenue (Quarterly) | 12.59B |
| Total Expenses (Quarterly) | 11.66B |
| EPS Diluted (Quarterly) | 0.5324 |
| Gross Profit Margin (Quarterly) | 52.64% |
| Profit Margin (Quarterly) | 7.37% |
| Earnings Yield | 3.11% |
| Operating Earnings Yield | 4.41% |
| Normalized Earnings Yield | 3.139 |